- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02983383
Effect of TAP Block for Postoperative Pain Control After Varicocele Operations.
June 13, 2018 updated by: Ömer Faruk Boran, Kahramanmaras Sutcu Imam University
Effect of TAP Block for Postoperative Pain Control After Varicocele Operations on Analgesia Quality and Postoperative Analgesic Consumption
TAP block is the administration of local anesthetic agents into the anatomic neurofascial cavity between the internal oblique and transversus abdominis muscle in the antero-lateral region of the abdomen to block the anterior branches of the thoracic intercostal (T7-T12) and first lumbar (L1) nerves.
TAP block may be a good method for postoperative pain control.
We aim to show the effect of TAP block administration on analgesic consumption after varicocelectomy operations, side effects linked to analgesic use and analgesic quality.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will include 50 patients aged from 18-45 years in ASA I-II risk group undergoing varicocelectomy operations under elective conditions, randomized with a lottery method.
Patients will be informed of the study and included in the study after giving permission with a patient consent form.
Patients will be divided into two groups; TAP group (Group T, n=25) and P (Group P, n=25).
Both groups will be taken for operation under spinal anesthesia.
Those with contraindications for spinal anesthesia, with coagulopathy, with known allergy to the medications used, with infection in the operated area, and those who do not volunteer will be excluded from the study.
At the end of the operation, patients in Group T in the supine position will have a USI probe placed at the middle point between the costal edge and iliac crest (within the Petit triangle) after necessary antiseptic conditions are ensured.
Then after the abdominal muscle layers are observed, the needle tip will be advanced through the muscle layers and pass the fascia, feeling the fascial click, monitored by USI in controlled fashion.
After feeling the second click (passing the internal oblique muscle fascia), a test dose of 0.5-1 ml saline will be administered to determine the localization of the needle tip.
Then noting the location, with frequent aspiration local anesthetic agent will be administered to the neurofascial plane for TAP block.
Patients in Group P will have adjuvant added to spinal anesthesia.
Patients in both groups will have pain scores assessed at 2, 4, 6, 12 and 24 hours postoperative at rest and coughing with VAS (visual analog scale) (pain severity: 0 no pain to 10 most severe pain experienced to date) and values will be recorded.
When patients are in pain, analgesic agent will be administered according to patient controlled analgesia protocol.
The time of first requirement for analgesic agent and the amount of analgesic agent used in 24 hours will be recorded for patients.
Side effects like postoperative nausea, vomiting, or itching will be noted.
Additionally, patient satisfaction will be assessed by asking if the surgical method they experienced was bad, moderate, good or very good and recorded.
Study Type
Interventional
Enrollment (Actual)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kahramanmaras, Turkey, 46000
- Kahramanmaras Sutcu Imam University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
18-45 year old ASA I-II patient group
Exclusion Criteria:
- Contraindications for spinal anesthesia
- Coagulopathy
- Known allergy to medications used
- Infection in the operated area
- Non-volunteer patient
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: TAP block group (Group T)
At the end of the operation, patients in Group T in the supine position will have a USI probe placed at the middle point between the costal edge and iliac crest (within the Petit triangle) after necessary antiseptic conditions are ensured.
Then after the abdominal muscle layers are observed, the needle tip will be advanced through the muscle layers and pass the fascia, feeling the fascial click, monitored by USI in controlled fashion.
After feeling the second click (passing the internal oblique muscle fascia), a test dose of 0.5-1 ml saline will be administered to determine the localization of the needle tip.
Then noting the location, with frequent aspiration local anesthetic agent will be administered to the neurofascial plane for TAP block.
|
At the end of the operation, patients in Group T in the supine position will have a USI probe placed at the middle point between the costal edge and iliac crest (within the Petit triangle) after necessary antiseptic conditions are ensured.
Then after the abdominal muscle layers are observed, the needle (Stimuplex Ultra 22G, 100mm, B.Braun, Germany) tip will be advanced through the muscle layers and pass the fascia, feeling the fascial click, monitored by USI in controlled fashion.
After feeling the second click (passing the internal oblique muscle fascia), a test dose of 0.5-1 ml saline will be administered to determine the localization of the needle tip.
Then noting the location, with frequent aspiration local anesthetic agent will be administered to the neurofascial plane for TAP block.
|
ACTIVE_COMPARATOR: Group without TAP (Group P)
Patients in Group P will have adjuvant added to spinal anesthesia.
|
Patients in Group P will have adjuvant added to spinal anesthesia (25 G, Quincke spinal anesthesia needle, Egemen,Turkey).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VAS (visual analog scale)
Time Frame: 24 Hours
|
VAS (visual analog scale) (pain severity: 0 no pain to 10 most severe pain experienced to date) score changes in the postoperative period at rest and coughing
|
24 Hours
|
Postoperative side effects
Time Frame: 24 Hours
|
questionnaire for postoperative nausea, vomiting, numbness and itching
|
24 Hours
|
Patient satisfaction
Time Frame: 24 Hours
|
questionnaire for patient satisfaction
|
24 Hours
|
time to first analgesic
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 1, 2016
Primary Completion (ACTUAL)
May 18, 2018
Study Completion (ACTUAL)
June 13, 2018
Study Registration Dates
First Submitted
November 30, 2016
First Submitted That Met QC Criteria
December 2, 2016
First Posted (ESTIMATE)
December 6, 2016
Study Record Updates
Last Update Posted (ACTUAL)
June 14, 2018
Last Update Submitted That Met QC Criteria
June 13, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 53
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Varicocele
-
First Affiliated Hospital, Sun Yat-Sen UniversityUnknownVaricocele; Male Infertile;VaricocelectomyChina
-
Sohag UniversityUnknownICSI AZOOSPERMIA VARICOCELEEgypt
-
Assiut UniversityNot yet recruiting
-
Assiut UniversityNot yet recruiting
-
Feng PanCompleted
-
Ömer Faruk BoranUnknown
-
Medical University of WarsawUnknown
-
Seoul National University HospitalCompletedVaricoceleKorea, Republic of
-
Yale UniversityUniversity of Colorado, Denver; Eunice Kennedy Shriver National Institute of... and other collaboratorsTerminatedInfertility | PregnancyUnited States
-
Al-Yasmeen Fertility and Gynecology CenterBanon IVF Center Assiut, Egypt; Elite Fertility and Gynecology Center, Cairo... and other collaboratorsNot yet recruitingInfertility, Male
Clinical Trials on TAP block group (Group T)
-
Yuzuncu Yıl UniversityCompletedComparison | EvaluationTurkey
-
Fatih Sultan Mehmet Training and Research HospitalCompletedAnesthesia and Analgesia | Anesthesia, Regional | Bariatric Surgical ProceduresTurkey
-
University of Massachusetts, WorcesterNot yet recruitingPost-operative Pain
-
Biruni UniversityCompleted
-
Medipol UniversityCompleted
-
Tokat Gaziosmanpasa UniversityCompletedIntraoperative Complications | Abdominal Hysterectomy (& Wertheim)Turkey
-
Federal University of São PauloUnknownRenal Insufficiency, Chronic | Kidney Transplantation | Acute Pain | Anesthesia, ConductionBrazil
-
Ankara City Hospital BilkentCompleted
-
Tokat Gaziosmanpasa UniversityUnknown
-
Prof. Dr. Cemil Tascıoglu Education and Research...Completed